Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Radiother Oncol. 2015 May 13;115(3):373–378. doi: 10.1016/j.radonc.2015.05.005

Table 2.

Selected dose-volume statistics for other organ-at-risk in IMPT in the static and 1 error scenarios, as well as the values in IMRT plan. IMPT dose-volume values were either statistically significantly smaller than IMRT value, or not significantly different from IMRT values, from paired Wilcoxon signed-rank tests.

IMRT IMPT
Static
IMPT
Worst
IMPT
Average
+3%
IMPT
Average
−3%
IMPT
Average 0%
Bowel
V40Gy
(%)
Median
(Min-
Max)
20.5
(12.2–29.7)
18.4
(10.1–27.1)
22.5
(12.8–29.9)
16.2
(8.9–23.8)
20.1
(10.6–28.5)
18.0
(9.8–26.2)
p-value Reference 0.01 0.77 <.01 0.01 <.01
Bowel
DMean
(Gy)
Median
(Min-
Max)
23.9
(20.3–30.8)
14.8
(10.4–20.4)
16.9
(11.9–21.9)
14.2
(10.1–19.5)
15.7
(10.7–21.5)
14.9
(10.4–20.5)
p-value Reference <.01 <.01 <.01 <.01 <.01
Rectum
V30Gy
(%)
Median
(Min-
Max)
80.6
(49.4–99.3)
62.9
(49.3–94.1)
77.7
(66.7–99.0)
62.1
(49.0–94.7)
69.5
(54.7–96.5)
65.3
(51.3–95.1)
p-value Reference 0.06 0.43 0.05 0.32 0.13
Rectum
DMean
(Gy)
Median
(Min-
Max)
40.9
(29.8–47.1)
34.1
(29.1–45.1)
40.5
(33.8–47.9)
32.5
(28.8–43.9)
36.3
(29.6–46.3)
34.3
(29.2–45.1)
p-value Reference <.01 0.38 <.01 0.05 0.01
Bladder
V45Gy
(%)
Median
(Min-
Max)
44.0
(22.0–79.2)
31.9
(22.6–55.7)
52.5
(29.9–73.1)
22.2
(14.0–48.4)
43.4
(27.4–63.7)
32.6
(20.6–56.0)
p-value Reference 0.04 0.16 <.01 0.85 0.04
Bladder
DMean
(Gy)
Median
(Min-
Max)
42.5
(32.2–46.6)
37.5
(29.2–39.8)
40.6
(32.3–45.7)
36.2
(27.6–38.7)
39.0
(31.3–41.4)
37.5
(29.3–39.8)
p-value Reference <.01 0.02 <.01 <.01 <.01
Rt
Femoral
Head
V30Gy(%)
Median
(Min-
Max)
12.3
(10.4–13)
2.8
(0–23.9)
10.8
(2.6–37.9)
2.3
(0–22.7)
2.8
(0–25.1)
2.7
(0–23.9)
p-value Reference 0.06 0.43 0.05 0.32 0.13
Lt
Femoral
Head
V30Gy(%)
Median
(Min-
Max)
12.7
(7.6–13.6)
5.3
(0–25.0)
16.0
(2.5–41.0)
4.7
(0–23.7)
5.8
(0–25.8)
5.1
(0–24.4)
p-value Reference 0.13 0.19 0.05 0.13 0.11